Abstract:OBJECTIVE To investigated the effects of INI-0602 on nociceptive reflex,depression-associated andanxiety-related behaviors caused by neuropathic pain in sciatic nerve injury rats.METHODS Male rat were subjected to sciatic nerve injury（SNI）or sham surgery.Rat received daily treatment with INI-0602 intrathecally,at a dose of 0.25μg/10μL.The response frequency to mechanical allodynia in animals was measured with von Frey hairs on day 1,3,5,7,14,21.Rats were evaluated in the forced swimming test（FST）test,tail suspension test（TST）,sucrose preference test（SPT）for depression-like behavior.We performed open field test（OFT）and elevated plus-maze test（EPM）to evaluate anxiety-associated behaviors.Besides,we investigated the alterations of NMDA receptor and the brain-derived neurotrophic factor（BDNF）and also the expression of connexin43 and connexin32,structure protein of gap junction channel,on the protein level and the number of activated astrocyte showed by immunohistochemical.RESULTS The SNI procedure produced mechanical allodynia and accompanied with depressive-like and anxiety-like behavior.Treatment with INI-0602 produced a significant analgesic effect in SNI rats at day 7（model+NS:11.017±1.506 g;model+INI-0602:31.157±1.532 g,P＜0.01）,and still obviously on the 21th day（31.067±1.787,P＜0.01）.INI-0602 could also improve the performance of sciatic nerve injury rats among program behavior tests related to depression and anxiety.In parallel with relief of pain,the alterations of NMDA receptor and the brain-derived neurotrophic factor（BDNF）,involved in central sensitization and synaptic plasticity,were investigated.INI-0602 not only could inhibited spared nerve injury induced up-regulated of NR2B and phosphorylation NR2B in early and late neuropathic pain（early phase:Nr2b:2.897±0.228,P＜0.01;p-Nr2b:2.984±0.236,P＜0.01;late phase:Nr2b:2.594±0.187,P＜0.01;p-Nr2b:3.124±0.330,P＜0.01）,but also could inhibit the increased of BDNF in the early（model+NS:3.637±0.381,model+INI-0602:1.148±0.372,P＜0.01）and upregulate the BDNF in late stage（model+NS:0.438±0.103,model+INI-0602:1.222±0.092,P＜0.01）.Meanwhile,INI-0602 significantly decreased the expression of connexin43 and connexin32,structure protein of gap junction channel,on the protein level and the number of activated astrocyte showed by immunohistochemical.CONCLUSION INI-0602 blocked behavioral changes induced by neuropathic pain,suggesting that it might be a promising pharmacological approach of painemotion diseases.

The gap junction inhibitor INI-0602 attenuates mechanical allodynia and depression-like behaviors induced by spared nerve injury in rats

Mechanical allodynia and affective behavior are improved by INI-0602,a gap junction hemichannel inhibitor,in a rat model of neuropathic pain induced by sciatic nerve injury

Itaconate as a Promising Therapy for Neuropathic Pain and Inflammatory Pain

Dimethyl Itaconate Inhibits Neuroinflammation to Alleviate Chronic Pain in Mice.

Delayed Inhibition of ERK and P38 Attenuates Neuropathic Pain Without Affecting Motor Function Recovery after Peripheral Nerve Injury.

PCC0208009, an indirect IDO1 inhibitor, alleviates neuropathic pain and co-morbidities by regulating synaptic plasticity of ACC and amygdala

The effect of intrathecal administration of glial activation inhibitors on dorsal horn BDNF overexpression and hind paw mechanical allodynia in spinal nerve ligated rats

Behavioral and Morphological Evidence for the Involvement of Glial Cells in the Antinociceptive Effect of Najanalgesin in A Rat Neuropathic Pain Model

Changes of Connexin 43 and 32 expression in the dorsal horn of spinal cord of rat with neuropathic pain and analgesic effect of carbenoxolone by intrathecal injection

Effect of Intrathecal Sufentanil and Protein Kinase C Inhibitor on Pain Threshold and the Expression of NMDA Receptor/cgrp in Spinal Dorsal Horn in Rats with Neuropathic Pain

Inhibition of the spinal astrocytic JNK/MCP-1 pathway activation correlates with the analgesic effects of tanshinone IIA sulfonate in neuropathic pain

BIX01294, a G9a Inhibitor, Alleviates Nerve Injury-induced Pain Hypersensitivities During Both Development and Maintenance Periods

REGULATION OF Cx43 AND GLT-1 ON PAIN BEHAVIOR IN RATS WITH TRIGEMINAL NEURALGIA

Spinal Ninjurin2 contributes to the neuropathic pain via NF-κB-mediated neuroinflammation in the spared sciatic nerve injury rats

EFFECT OF GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR ON RAT NEUROPATHIC PAIN

INTRATHECAL MINOCYCLINE ON SPINAL NMDA RECEPTOR 1 SUBUNIT EXPRESSION IN RAT MODELS OF NEUROPATHIC PAIN

Activation of GPR55 alleviates neuropathic pain and chronic inflammation

A Peptide C-Jun N-Terminal Kinase (JNK) Inhibitor Blocks Mechanical Allodynia after Spinal Nerve Ligation: Respective Roles of JNK Activation in Primary Sensory Neurons and Spinal Astrocytes for Neuropathic Pain Development and Maintenance

Analgesic Effect of SKI306X on Chronic Postischemic Pain and Spinal Nerve Ligation-Induced Neuropathic Pain in Mice

Intrathecal Carbenoxolone Inhibits Neuropathic Pain and Spinal Wide-Dynamic Range Neuronal Activity in Rats after an L5 Spinal Nerve Injury

Intrathecal Sirna Against GPNMB Attenuates Nociception in a Rat Model of Neuropathic Pain.